Total Payments
$20,297
2024 Payments
$1,386
Companies
55
Transactions
420
Medicare Patients
1,612
Medicare Billing
$272,540
Payment Breakdown by Category
Food & Beverage$16,005 (78.9%)
Education$3,305 (16.3%)
Travel$986.82 (4.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,005 | 408 | 78.9% |
| Education | $3,305 | 9 | 16.3% |
| Travel and Lodging | $986.82 | 3 | 4.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $4,737 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,640 | 49 | $0 (2024) |
| Covidien LP | $1,332 | 15 | $0 (2019) |
| GlaxoSmithKline, LLC. | $1,202 | 61 | $0 (2024) |
| Medtronic, Inc. | $1,153 | 13 | $0 (2024) |
| Stryker Corporation | $920.23 | 10 | $0 (2018) |
| TESARO, Inc. | $865.23 | 22 | $0 (2019) |
| ABBVIE INC. | $839.04 | 34 | $0 (2024) |
| COLOPLAST CORP | $693.49 | 10 | $0 (2021) |
| Baxter Healthcare | $683.96 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,386 | 40 | GlaxoSmithKline, LLC. ($240.05) |
| 2023 | $2,323 | 34 | Intuitive Surgical, Inc. ($980.98) |
| 2022 | $2,119 | 48 | New Wave Endo-Surgical Corp. ($464.00) |
| 2021 | $1,943 | 53 | AstraZeneca Pharmaceuticals LP ($285.32) |
| 2020 | $1,144 | 44 | GlaxoSmithKline, LLC. ($189.60) |
| 2019 | $3,397 | 82 | Covidien LP ($807.37) |
| 2018 | $5,354 | 65 | Intuitive Surgical, Inc. ($3,227) |
| 2017 | $2,631 | 54 | Stryker Corporation ($777.25) |
All Payment Transactions
420 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $0.75 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | CONMED Corporation | AIRSEAL (Device) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: GENERAL SURGERY | ||||||
| 11/14/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $33.30 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | PFIZER INC. | LORBRENA (Drug) | Food and Beverage | In-kind items and services | $98.65 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | Helsinn Therapeutics (U.S.), Inc. | AKYNZEO (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | Integra LifeSciences Corporation | CODMAN CERTAS (Device), CUSA CLARITY, CODMAN HAKIM | Food and Beverage | In-kind items and services | $31.08 | General |
| Category: Neuro Critical Care | ||||||
| 10/18/2024 | Myriad Genetic Laboratories, Inc. | PRECISETUMOR (Device) | Food and Beverage | In-kind items and services | $108.81 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $32.17 | General |
| Category: ONCOLOGY | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $34.52 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $126.81 | General |
| Category: Oncology | ||||||
| 08/21/2024 | Urgo Medical North America, LLC | VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP (Device) | Food and Beverage | In-kind items and services | $47.83 | General |
| Category: WOUND CLEANSER | ||||||
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Oncology | ||||||
| 07/17/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: Oncology | ||||||
| 07/17/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: ONCOLOGY | ||||||
| 07/15/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $2.73 | General |
| Category: ONCOLOGY | ||||||
| 07/03/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: ONCOLOGY | ||||||
| 05/21/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $129.55 | General |
| Category: SURGERY | ||||||
| 05/15/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Oncology | ||||||
| 05/14/2024 | Medtronic, Inc. | LIGASURE (Device) | Food and Beverage | In-kind items and services | $155.42 | General |
| Category: Vessel Sealing | ||||||
| 05/09/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: ONCOLOGY | ||||||
| 04/11/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: Oncology | ||||||
| 04/09/2024 | Boston Scientific Corporation | Upsylon (Device) | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: Upsylon_URO | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 259 | 486 | $132,600 | $34,245 |
| 2022 | 16 | 454 | 13,708 | $372,436 | $69,352 |
| 2021 | 18 | 488 | 22,373 | $585,590 | $89,200 |
| 2020 | 14 | 411 | 5,660 | $458,127 | $79,744 |
Total Patients
1,612
Total Services
42,227
Medicare Billing
$272,540
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 93 | 133 | $46,510 | $12,641 | 27.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 11 | 67 | $34,840 | $7,651 | 22.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 24 | 24 | $13,680 | $4,102 | 30.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 51 | 51 | $6,970 | $2,186 | 31.4% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 11 | 66 | $7,260 | $1,706 | 23.5% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 14 | 15 | $6,600 | $1,547 | 23.4% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 15 | 16 | $6,240 | $1,484 | 23.8% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 11 | 84 | $5,040 | $1,161 | 23.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 16 | $3,360 | $1,084 | 32.3% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 14 | 14 | $2,100 | $682.36 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 141 | 242 | $75,020 | $25,450 | 33.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 13 | 119 | $61,880 | $14,439 | 23.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 27 | 27 | $15,390 | $4,639 | 30.1% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2022 | 13 | 78 | $19,500 | $4,517 | 23.2% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2022 | 13 | 140 | $15,400 | $3,880 | 25.2% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 86 | 86 | $11,180 | $3,740 | 33.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 18 | $7,380 | $2,614 | 35.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 30 | $6,300 | $2,077 | 33.0% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2022 | 13 | 131 | $7,860 | $1,917 | 24.4% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 29 | 29 | $4,350 | $1,416 | 32.6% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2022 | 15 | 16 | $6,240 | $1,380 | 22.1% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 14 | 15 | $6,600 | $1,332 | 20.2% |
| J9267 | Injection, paclitaxel, 1 mg | Office | 2022 | 11 | 10,457 | $83,656 | $1,010 | 1.2% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2022 | 12 | 920 | $41,400 | $760.83 | 1.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 13 | 1,340 | $9,380 | $128.91 | 1.4% |
About Dr. Fikret Atamdede, M.D
Dr. Fikret Atamdede, M.D is a Gynecologic Oncology healthcare provider based in Torrance, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578502480.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fikret Atamdede, M.D has received a total of $20,297 in payments from pharmaceutical and medical device companies, with $1,386 received in 2024. These payments were reported across 420 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($16,005).
As a Medicare-enrolled provider, Atamdede has provided services to 1,612 Medicare beneficiaries, totaling 42,227 services with total Medicare billing of $272,540. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecologic Oncology
- Location Torrance, CA
- Active Since 06/06/2006
- Last Updated 11/12/2024
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1578502480
Products in Payments
- Da Vinci Surgical System (Device) $4,737
- ZEJULA (Drug) $1,529
- LYNPARZA (Drug) $1,316
- vitagel (Device) $777.25
- LigaSure (Device) $635.46
- TISSEEL (Biological) $620.84
- LIGASURE (Device) $573.11
- Rubraca (Drug) $498.45
- Valleylab FT10 (Device) $452.98
- ALTIS (Device) $409.79
- KEYTRUDA (Biological) $401.65
- Orilissa (Drug) $387.61
- Lenvima (Drug) $363.32
- MYRISK (Device) $362.66
- TUKYSA (Drug) $353.02
- JEMPERLI (Biological) $349.36
- HEMOBLAST BELLOWS (Device) $271.66
- SIGNIA (Device) $198.34
- VARUBI (Drug) $189.10
- AKYNZEO (Drug) $183.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.